Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
about
Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.Low-density lipoprotein size and cardiovascular risk assessment.Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles.In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis.Low-density lipoprotein 4: a novel predictor of coronary artery disease severity.
P2860
Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Influence of simvastatin on LD ...... nd mixed hyperlipoproteinemia.
@en
Influence of simvastatin on LD ...... nd mixed hyperlipoproteinemia.
@nl
type
label
Influence of simvastatin on LD ...... nd mixed hyperlipoproteinemia.
@en
Influence of simvastatin on LD ...... nd mixed hyperlipoproteinemia.
@nl
prefLabel
Influence of simvastatin on LD ...... nd mixed hyperlipoproteinemia.
@en
Influence of simvastatin on LD ...... nd mixed hyperlipoproteinemia.
@nl
P2093
P356
P1476
Influence of simvastatin on LD ...... nd mixed hyperlipoproteinemia.
@en
P2093
P304
P356
10.1055/S-2002-32150
P577
2002-06-01T00:00:00Z